Bermudian (re)insurer ACE was the topic of much conversation last week as analysts published conflicting and, at times, controversial equity research on the company.
Bermudian (re)insurer ACE was the topic of much conversation last week as analysts published conflicting and, at times, controversial equity research on the company.